The 2025 contraction marks the steepest decline in both the number of billionaire promoters and their aggregate wealth since 2012.
If Xi Jinping is dethroned in the future, the instrument for that may well be embedded within the PLA, notes former foreign secretary Shyam Saran.
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
Covid is growing milder with time but an occasional surge in cases is expected because the virus that causes it is now endemic and constantly evolving, say scientists while assuring that there is no cause for concern.
IIT Bombay's alumni raised a whopping $7 million for their alma mater at a function to celebrate 50 years of the premier institution to set up a bioscience centre.
The student was detained three days after the ISIS India head Haris Farooqi alias Harish Ajmal Farukhi and his associate Anurag Singh alias Rehan were arrested in Dhubri district after they had crossed over from Bangladesh.
The transmission of dengue is closely associated with three key factors -- rainfall, humidity and temperature -- that dictate the geographies in which it spreads and the transmission rate of the viral infection caused by the dengue virus (DENV), and transmitted to humans through the bite of infected mosquitoes.
As concerns mounted and some people wondered whether this could possibly turn out to be another Covid, pulmonologist Anurag Agrawal said he doesn't expect to see a massive wave.
Sun Pharmaceutical Industries on Tuesday said its arm DUSA Pharmaceuticals Inc has reached settlement with Biofrontera to resolve a litigation over misappropriation of trade secrets and unfair practice, following which DUSA will receive $22.5 million (nearly Rs 170 crore). In 2018, DUSA Pharmaceuticals had filed a suit at the US District Court of Massachusetts against Biofrontera Inc Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG (together known as Biofrontera) alleging "misappropriation of trade secrets, tortious interference of contract and unfair trade practices".
Lumpy Skin Disease has spread in more than a dozen states including Gujarat, Rajasthan, Punjab and Haryana.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
This State-corporate 'cooperation' didn't begin with the arrival of the Modi government.
Many of the big licences, contracts, and even environmental clearances for the Adani group had come in the UPA's time, points out Shekhar Gupta.
Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income countries across the world.
GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller General of India (DCGI), Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella said
Senior virologist Shahid Jameel on Sunday resigned as the chairman of scientific advisory group of Indian SARS-CoV-2 Genomics Consortium, a forum set up by union government in December last year for laboratory and epidemiological surveillance of circulating strains of COVID-19 in India.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.
Germany's drug regulator has banned the sale of 80 generic medicines with immediate effect on the grounds that their clinical trials conducted by India's pharmaceutical research company GVK Biosciences were "insufficient".
The plant and associated facilities focus on manufacturing or packaging Amoxicilin-based products, which include semi-synthetic penicillin
The joint drug-discovery project of multinational pharma firm Wyeth and GVK Biosciences will fully take off within a month's time, following the establishment of a dedicated discovery chemistry research laboratory.
As part of its global expansion plans, Dabur Pharma has acquired the sales and distribution network of Thailand-based Bioscience for an undisclosed sum.
The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing 1,11,000 vials of the drug per month from July.
If the pandemic persists, at least a portion of the blame should go to greed and nationalism that got in the way of the world acting together, notes Prosenjit Datta.
500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.
Ajit Mishra, vice president, research, Religare Broking, answers your queries.
The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains, according to the researchers.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
Indian pharma firms under European drug regulator's scanner.
Negotiators from were expected to meet in New Delhi on August 28.
While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.
Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.
There is so far no evidence that the second wave of COVID-19 in the country is due to variants of the virus, but it is possible, said noted virologist Shahid Jameel.
This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.
Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.
Eminent virologist Shahid Jameel COVID-19 cases in the second wave also won't come down in as steady a fashion as they did after the first wave.
The Indian drug industry's dream of coming out with an own new chemical entity or an originally researched new drug has received a big boost. Balaglitazone, the diabetic drug molecule being developed by Dr Reddy's Laboratories, has showed encouraging results in the final lap of human clinical trials.
Ranbaxy, originally promoted by the Singh family, was acquired by Japan's Daiichi Sankyo late last year.
It's not every day that an undergraduate from India wins a scholarship to study at one of the prestigious universities in the world.
Central Institute of Medicinal and Aromatic Plants (CIMAP) opens admissions to its PhD programme.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances